Last deal

$400M

Amount

Post-IPO Debt

Stage

08.05.2023

Date

3

all rounds

$721.33M

Total amount

date founded

Financing round

General

About Company
TransMedics is a medical technology company that transforms organ transplant therapy for end-stage organ failure patients.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1998

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

The company has developed the Organ Care System (OCS), which is a portable organ perfusion, optimization, and monitoring system that addresses the limitations of cold storage. The OCS replicates near-physiologic conditions for donor organs outside of the human body, allowing for improved clinical outcomes and reduced learning curves. TransMedics provides technology and clinical service solutions to increase heart and lung transplant volume, ultimately benefiting patients across multiple disease states.
Contacts
Similar Companies
1000
Anuncia Medical

Anuncia Medical

Anuncia Medical's noninvasive device prevents shunt failure and revision brain surgery in patients with hydrocephalus and CSF disorders.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical, Medical Device

Location

Scottsdale, AZ, USA

total rounds

3

total raised

$19K
Restore Medical

Restore Medical

Restore Medical provides device-based therapy for congestive heart failure.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Or Yehuda, Israel

total rounds

2

total raised

$3.12M
Intersect ENT

Intersect ENT

Intersect ENT is a medical device company that provides therapy solutions for ENT physicians to improve patients' quality of life..

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Menlo Park, CA, USA

total rounds

7

total raised

$257.44M
Reflectance Medical

Reflectance Medical

Reflectance Medical has developed Mobile CareGuide, a sensor platform to noninvasively and continuously assess patient metabolic status.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Westborough, MA, USA

total rounds

1

total raised

$500K

Financials

Funding Rounds
16
3

Number of Funding Rounds

$721.33M

Money Raised

Their latest funding was raised on 08.05.2023. Their latest round Post-IPO Debt

Date 
Funding Round 
Investors 
Money Raised 
Lead 
08.05.2023
$400M
24.04.2020
1
$2.2M

CIBC Innovation Banking

CIBC Innovation Banking provides funding and strategic advice to innovation companies.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking, Advice

Location

Toronto, ON, Canada

count Of Investments

92

count Of Exists

9
Co-Investors
Investors
18
7

Number of lead investors

18

Number of investors

Investor 
Lead 
Round 
Partners 
No
Post-IPO Debt
No
Series C, Series D, Series E

CIBC Innovation Banking

CIBC Innovation Banking provides funding and strategic advice to innovation companies.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking, Advice

Location

Toronto, ON, Canada

count Of Investments

92

count Of Exists

9
Joe Hammer

Joe Hammer

Joe Hammer Co-Head of North American Life Science and Healthcare at CIBC Innovation Bank.

OrbiMed

OrbiMed

OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

559

count Of Exists

82

Sagamore Bioventures

Sagamore Bioventures is a US-based company that provides later stage venture investments.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services

count Of Investments

6

count Of Exists

1
Acquisitions
1
Acquiree Name 
Date 
Price 
Acquisition Name 
Summit Aviation acquired by TransMedics

Summit Aviation acquired by TransMedics

acquirer

TransMedics
TransMedics

date

01.08.2023

type

Acquisition
Summit Aviation

Summit Aviation

Summit Aviation offers private charter flights, aircraft management, sales, and flight training.

Sector

Aerospace and Defense

Subsector

Aerospace

Keywords

Aerospace, Air Transportation

People

Founders
1
Waleed Hassanein
Waleed Hassanein

Waleed Hassanein

Dr. Waleed Hassanein is president , CEO and director of TransMedics, Inc. He founded the company in August, 1998. As an experienced medical device executive, Waleed brings more than eleven years of experience in establishing and leading executive teams through the clinical development, market launch and commercial rollout of the company’s breakthrough Organ Care System (OCS™) technology in the European and US markets. Waleed has successfully raised >$120 million of private equity capital to develop and commercialize the OCS™ technology and has established world-class clinical advocates for the OCS™ technology world-wide from the key opinion leaders in organ transplantation. Waleed received his M.D. from Georgetown University where he also completed two years of General Surgery residency. He completed his pre-medical education from University of London and Cairo University School of Medicine.

current job

TransMedics
TransMedics

organization founded

1

Waleed Hassanein

Employee Profiles
41
Saverio La Francesca

Saverio La Francesca

Principal Cardiothoracic Surgeon

Joshua Shedd

It administrator and project manager

Mostafa Raziq

Senior electrical design engineer at transmedics, inc

Michael O’Hara

Senior Director of Quality Assurance

Jacqueline Sneve

Vice President, Healthcare Economics and Reimbursement

John Carey

Vice President of Operations

Waleed Hassanein

Waleed Hassanein

President & CEO

Christine Brauer

Vice President, Regulatory Affairs

Activity

Recent News
19
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week